Chemoenzymatic synthesis with the Pasteurella hyaluronan synthase; production of a multitude of defined authentic, derivatized, and analog polymers
Proteoglycan Research · 2024
DOI: 10.1002/pgr2.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proteoglycan Research, 2024. Verfasst von Paul L DeAngelis. Beteiligte Einrichtung: Department of Biochemistry and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Hyaluronan (HA; [‐3‐GlcNAc‐1‐beta‐4‐GlcA‐1‐beta] n ), an essential matrix polysaccharide of vertebrates and the molecular camouflage coating in certain pathogens, is polymerized by “HA synthase” (HAS) enzymes. Three HAS classes have been identified with biotechnological utility, but only the Class II PmHAS from Pasteurella multocida Type A has been useful for preparation of very defined HA polymers in vitro. Two general chemoenzymatic strategies with different size products are possible: (1) repetitive step‐wise extension reactions by sequential addition of a single monosaccharide from a donor UDP‐sugar onto an acceptor (or “primer”) comprised of a short glycosaminoglycan chain (e.g., HA di‐, tri‐ or tetrasaccharide) or an artificial glucuronide yielding homogeneous oligosaccharides in the range of 2 to ~20 monosaccharide units ( n = 1 to ~10), or (2) “one‐pot” polymerization reactions employing acceptor‐mediated synchronization with stoichiometric size control yielding quasi‐monodisperse (i.e., polydispersity approaching 1; very narrow size distributions) polysaccharides in the range of ~7 kDa to ~2 MDa ( n = ~17 to 5000). In either strategy, acceptors containing non‐carbohydrate functionalities (e.g., biotin, fluorophores, amines) can add useful moieties to the reducing termini of HA chains at 100% efficiency. As a further structural diversification, PmHAS can utilize a variety of unnatural UDP‐sugar analogs thus adding novel groups (e.g., trifluoroacetyl, alkyne, azide, sulfhydryl) along the HA backbone and/or at its nonreducing terminus. This review discusses the current understanding and recent advances in HA chemoenzymatic synthesis methods using PmHAS. This powerful toolbox has potential for creation of a multitude of HA‐based probes, therapeutics, drug conjugates, coatings, and biomaterials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Paul L DeAngelis
Förderung
- NHLBI NIH HHS
Zitieren
APA
DeAngelis, P. L. (2024). Chemoenzymatic synthesis with the Pasteurella hyaluronan synthase; production of a multitude of defined authentic, derivatized, and analog polymers. Proteoglycan Research. https://doi.org/10.1002/pgr2.70000
Vancouver
DeAngelis PL. Chemoenzymatic synthesis with the Pasteurella hyaluronan synthase; production of a multitude of defined authentic, derivatized, and analog polymers. Proteoglycan Research. 2024. doi:10.1002/pgr2.70000
BibTeX
@article{DeAngelis2024,
author = {DeAngelis, Paul L},
title = {Chemoenzymatic synthesis with the Pasteurella hyaluronan synthase; production of a multitude of defined authentic, derivatized, and analog polymers},
journal = {Proteoglycan Research},
year = {2024},
doi = {10.1002/pgr2.70000}
}
EUVIMED